Therapy-related myeloid leukemia

被引：126

作者：

Thirman, MJ

Larson, RA

机构：

[1] UNIV CHICAGO,PRITZKER SCH MED,HEMATOL ONCOL SECT,CHICAGO,IL 60637

[2] UNIV CHICAGO,CANC RES CTR,CHICAGO,IL 60637

来源：

HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA | 1996年 / 10卷 / 02期

关键词：

D O I：

10.1016/S0889-8588(05)70340-3

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

One of the most serious possible consequences of cancer therapy is the development of a second cancer, especially leukemia. Several distinct subsets of therapy-related leukemia can be distinguished currently. These include classic therapy-related myeloid leukemia, leukemia that follows treatment with agents that inhibit topoisomerase II, acute lymphoblastic leukemia, and leukemias with 21q22 rearrangements or inv(16) or t(15;17). These types of leukemia are discussed in detail in this article.

引用

收藏

页码：293 / &

页数：29

相关论文

共 147 条

[1]

ABRAMS J, 1994, PHYSICIAN DATA 0729

[2] IMPLICATION OF PRIOR TREATMENT WITH DRUG-COMBINATIONS INCLUDING INHIBITORS OF TOPOISOMERASE-II IN THERAPY-RELATED MONOCYTIC LEUKEMIA WITH A 9-11 TRANSLOCATION [J].

ALBAIN, KS ;

LEBEAU, MM ;

ULLIRSCH, R ;

SCHUMACHER, H .

GENES CHROMOSOMES & CANCER, 1990, 2 (01) :53-58

[3] INCREASED RISK OF SECONDARY ACUTE NONLYMPHOCYTIC LEUKEMIA AFTER EXTENDED-FIELD RADIATION-THERAPY COMBINED WITH MOPP CHEMOTHERAPY FOR HODGKINS-DISEASE [J].

ANDRIEU, JM ;

IFRAH, N ;

PAYEN, C ;

FERMANIAN, J ;

COSCAS, Y ;

FLANDRIN, G .

JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (07) :1148-1154

[4] BONE-MARROW TRANSPLANTATION FOR PATIENTS WITH MYELODYSPLASIA - PRETREATMENT VARIABLES AND OUTCOME [J].

APPELBAUM, FR ;

BARRALL, J ;

STORB, R ;

FISHER, LD ;

SCHOCH, G ;

RAMBERG, RE ;

SHULMAN, H ;

ANASETTI, C ;

BEARMAN, SI ;

BEATTY, P ;

BENSINGER, WI ;

BUCKNER, CD ;

CLIFT, RA ;

HANSEN, JA ;

MARTIN, P ;

PETERSEN, FB ;

SANDERS, JE ;

SINGER, J ;

STEWART, P ;

SULLIVAN, KM ;

WITHERSPOON, RP ;

THOMAS, ED .

ANNALS OF INTERNAL MEDICINE, 1990, 112 (08) :590-597

[5] ACUTE-LEUKEMIA WITH T(4-11) IN PATIENTS PREVIOUSLY EXPOSED TO CARCINOGENS [J].

ARCHIMBAUD, E ;

CHARRIN, C ;

GUYOTAT, D ;

MAGAUD, JP ;

GENTILHOMME, O ;

FIERE, D .

BRITISH JOURNAL OF HAEMATOLOGY, 1988, 69 (04) :467-470

[6] BANDED CHROMOSOME ANALYSIS IN PATIENTS WITH TREATMENT-ASSOCIATED ACUTE NONLYMPHOCYTIC LEUKEMIA [J].

ARTHUR, DC ;

BLOOMFIELD, CD .

CANCER GENETICS AND CYTOGENETICS, 1984, 12 (03) :189-199

[7] TREATMENT OF THERAPY-RELATED ACUTE MYELOGENOUS LEUKEMIA AND MYELODYSPLASTIC SYNDROMES [J].

BALLEN, KK ;

ANTIN, JH .

HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1993, 7 (02) :477-493

[8]

BENNETT J M, 1987, Hematologic Pathology, V1, P99

[9]

BERNARD OA, 1994, ONCOGENE, V9, P1039

[10] A HEMATOLOGICAL REMISSION BY CLONAL HEMATOPOIESIS AFTER TREATMENT WITH RECOMBINANT HUMAN GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTOR AND ERYTHROPOIETIN IN A PATIENT WITH THERAPY-RELATED MYELODYSPLASTIC SYNDROME [J].

BESSHO, M ;

ITOH, Y ;

KATAUMI, S ;

KAWAI, N ;

MATSUDA, A ;

JINNAI, I ;

SAITOH, M ;

HIRASHIMA, K ;

MINAMIHISAMATSU, M .

LEUKEMIA RESEARCH, 1992, 16 (02) :123-131

← 1 2 3 4 5 6 7 8 9 10 →